A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome
| Image |  |
|---|---|
| Description | scientific article published on 19 September 2020 |
| Author/s |
author: Xavier Mariette Saba Nayar |
| Publication date | September 19, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |